These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12533691)

  • 1. Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders.
    Kremer M; Spitzer M; Mandl-Weber S; Stecker K; Schmidt B; Höfler H; Quintanilla-Martínez L; Fend F
    Lab Invest; 2003 Jan; 83(1):107-14. PubMed ID: 12533691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCR analysis of IgH-gene rearrangements in small lymphoid infiltrates microdissected from sections of paraffin-embedded bone marrow biopsy specimens.
    Kremer M; Cabras AD; Fend F; Schulz S; Schwarz K; Hoefler H; Werner M
    Hum Pathol; 2000 Jul; 31(7):847-53. PubMed ID: 10923923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection.
    Fend F; Quintanilla-Martinez L; Kumar S; Beaty MW; Blum L; Sorbara L; Jaffe ES; Raffeld M
    Am J Pathol; 1999 Jun; 154(6):1857-66. PubMed ID: 10362812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
    Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytometric detection of DNA amplified with fluorescent primers: applications to analysis of clonal bcl-2 and IgH gene rearrangements in malignant lymphomas.
    Barker RL; Worth CA; Peiper SC
    Blood; 1994 Feb; 83(4):1079-85. PubMed ID: 8111048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BCL-2/IgH and IgH gene rearrangements in bone marrow mononuclear cells of patients with non-Hodgkin's lymphoma].
    Zhang XH; Liang Y; Wang GJ; Ruan EB; Fu R; Qu W; Liu H; Guan J; Song J; Wang HQ; Wu YH; Xing LM; Wang XM; Wang J; Li LJ; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):379-84. PubMed ID: 21518492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates.
    Engels K; Oeschger S; Hansmann ML; Hillebrand M; Kriener S
    Hum Pathol; 2007 Sep; 38(9):1402-11. PubMed ID: 17560629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
    Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
    Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma.
    Shen DF; Zhuang Z; LeHoang P; Böni R; Zheng S; Nussenblatt RB; Chan CC
    Ophthalmology; 1998 Sep; 105(9):1664-9. PubMed ID: 9754175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of IgH gene rearrangement in B-cell non-Hodgkin's lymphoma and application of gel-scan method].
    Zhang XF; Zhou R; Mao ZR; Luo LK; Hu MJ; Yang SY; Li FM
    Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):513-7. PubMed ID: 15634445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2/IgH expression of diffuse large B-cell lymphoma cells in minimal bone marrow infiltration.
    Che YQ; Liu P; Luo Y; Shen D; Hao JJ; Yang L; Zhang CG; Qi J; Wang MR
    Clin Lab; 2014; 60(6):989-98. PubMed ID: 25016705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell/histiocyte-rich large B-cell lymphoma displays a heterogeneity similar to diffuse large B-cell lymphoma: a clinicopathologic, immunohistochemical, and molecular study of 30 cases.
    Wang J; Sun NC; Chen YY; Weiss LM
    Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):109-15. PubMed ID: 15894921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
    Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
    Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.
    Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD
    Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.